Development and psychometric testing of a breast cancer patient-profiling questionnaire
Alessandra Gorini,1,2 Ketti Mazzocco,1,2 Sara Gandini,2 Elisabetta Munzone,2 Gordon McVie,2 Gabriella Pravettoni1,2 1Department of Health Science, University of Milan, Milan, Italy; 2European Institute of Oncology, Milan, Italy Introduction: The advent of “personalized medicine”...
Enregistré dans:
Auteurs principaux: | Gorini A, Mazzocco K, Gandini S, Munzone E, McVie G, Pravettoni G |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2015
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/72ee9e56e6874d9d8a837d6051a7102b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
par: Criscitiello C, et autres
Publié: (2018) -
Profile of neratinib and its potential in the treatment of breast cancer
par: Feldinger K, et autres
Publié: (2015) -
Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry
par: Jessica Roelands, et autres
Publié: (2021) -
Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer
par: Stenehjem DD, et autres
Publié: (2014) -
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study
par: Ioannis Zerdes, et autres
Publié: (2021)